Zealand Pharma announces promising results from dapiglutide trial for obesity treatment

Zealand Pharma A/S (Nasdaq: ZEAL), a pioneer in peptide-based drug development, has shared topline results from its DREAM trial, evaluating the efficacy of low doses ... Read More